全球 COVID-19 诊断市场 – 行业趋势和 2029 年预测

 COVID-19 诊断市场分析和规模

美国疾病控制与预防中心 (CDC) 已开发出两种实验室检测方法，用于识别导致 COVID-19 的病毒 SARS-CoV-2。CDC 2019-新型冠状病毒 (2019-nCoV) 实时 RT-PCR 诊断试剂盒可检测呼吸道样本中的 SARS-CoV-2，是首个用于 COVID-19 诊断的检测方法，于 2020 年 2 月发布。2020 年 7 月，CDC 发布了 CDC 流感 SARS-CoV-2 (Flu SC2) 多重检测方法，允许公共卫生实验室在单个反应孔中运行三种检测方法。Flu SC2 多重检测方法使用更少的检测试剂，通量更高，并能为患者样本中是否存在 SARS-CoV-2、甲型流感和乙型流感核酸提供准确的结果。

Data Bridge Market Research 分析，2021 年 COVID-19 诊断市场规模为 467.6 亿美元，预计到 2029 年将达到 865.5 亿美元，2022 年至 2029 年预测期内的复合年增长率为 8.00%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

COVID-19 诊断市场范围和细分  

Market Definition

The novel coronavirus is a single-stranded RNA coronavirus that resembles existing SARS-CoV. As this spreads by close contact with an infected individual and is largely spread through respiratory droplets produced by coughing and sneezing. Coronavirus, which is now a global epidemic, was first discovered in the Chinese area of Wuhan. It is also known as coronavirus illness or COVID-19. RT-PCR, isothermal nucleic acid amplification, antibody detection, and other technologies are utilised in testing kits for the COVID-19 test, which is used to identify the SARS-CoV-2 virus. Serological tests are employed for population surveillance, diagnosis, and the identification of antibodies.

Global COVID-19 Diagnostics Market Dynamics

Drivers

•        Need for test kits in hospitals is a driver

The need for coronavirus test kits has expanded along with the coronavirus's widespread. With the aid of test kits, coronavirus identification has become more crucial than ever in order to control the infection's spread and boost the market expansion. Only specialised labs that are licenced to conduct the tests included in this kit, which are of the serology and molecular types. As the kits are based on techniques including real-time polymerase chain reactions, IgM ELISA tests, and microneutralization assays, samples are taken from the nose, sputum test, blood sample, throat swab, and nasal aspirate for testing. The demand for the industry is growing as a result of the global coronavirus outbreak.  As the number of patients in hospitals is increasing rapidly, the need for test kits in hospitals to diagnose the patients with symptoms is also increasing which is further drive the market growth.

•        Technological advancements in COVID-19 rapid testing

Vendors created a variety of innovative rapid testing kits, including cups, cards, and smart test kits. Saliva samples were employed in painless quick testing kits. Additionally, test kits with quicker findings were released on the market. Rapid testing is preferred over other COVID-19 testing kits as a result of these developments. For instance, Meril Diagnostics, an international medical firm with operations in India, produces the non-prescription CoviFind COVID-19 Rapid Antigen Self-Test, which is available and has received approval from the Indian Council of Medical Research (ICMR) for routine usage in India. The introduction of novel and innovative diagnostic tests, such as immunoenzymatic serological tests, rapid antigen tests, and RT PCR-based molecular tests, is expected to drive industry demand.

Opportunities

• Rising number of COVID-19 patients

With the rapidly increasing number of COVID-19 patients worldwide, healthcare professionals require a consistent supply of diagnostic kits, which is expected to have a significant impact on the COVID-19 diagnostics market from 2022 to 2029. The growing number of suspected cases and the need to ensure that test results are correct which has resulted in an increase in demand for more kits, as well as increased safety concerns and the need to diagnose and isolate infected persons, which are expected to boost market growth.

Restraints/Challenges

• Lack of knowledge regarding COVID-19

Lack of knowledge regarding COVID-19 and its symptoms, ability to increase in certain developing regions among professionals will obstruct the market's growth rate. Time required for result is more than 24 hours which is bit longer and will act as a restraint, and further challenge the growth of the COVID-19 Diagnostics market in the forecast period mentioned above. The increased number of false-positive and false-negative results is one of the main drawbacks of fast testing. A set of COVID-19 test kits contained instances of findings that were both falsely positive and falsely negative. When verified with alternate COVID-19 testing, individuals with COVID-19 symptoms both tested negative and positive. These incidents caused the use of COVID-19 fast test kits to decline in some countries.

This COVID-19 diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the COVID-19 diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 对 COVID-19 诊断市场的影响

COVID-19 对市场产生了积极影响，通过发现病人和人与人之间的传播，检测对控制和缓解疫情做出了重大贡献。全球最常用的 COVID-19 检测之一是快速抗原检测。这种诊断结果可以量化病毒蛋白的数量，可在 15 分钟内获得。然而，随着时间的推移，越来越多的人开始使用快速诊断试剂盒，供应商也开始生产高灵敏度的 COVID-19 快速检测试剂盒。

最新动态

• 2021 年 7 月，雅培在印度推出了 PanbioTM COVID-19 抗原自检，以扩展其快速诊断产品，满足家庭、工作场所和诊所的筛查要求。
• 2021 年 3 月，罗氏诊断宣布其 COVID-19 快速抗原检测获得美国食品药品监督管理局 (FDA) 的紧急使用授权 (EUA)，该检测旨在供医护专业人员在 COVID-19 患者的即时诊断环境中使用。

全球 COVID-19 诊断市场范围

COVID-19 诊断市场根据测试类型、产品、技术、样本类型、环境和最终用户进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

测试类型

• 分子检测
• 血清免疫测定
• 辅助诊断测试

 产品

• 聚合酶链式反应试剂盒
• 即时诊断（POC）检测试剂盒
• 免疫分析
• 仪器
• 试剂与试剂盒

 技术

• 聚合酶链式反应（PCR）
• 酶联免疫吸附试验 (ELISA)
• 横向流动免疫分析 (LFIA)
• 其他的

样品类型

• 口咽和鼻咽拭子
• 鼻拭子
• 血
• 其他的

 环境

• 基于实验室
• 护理点

 最终用户

• 医院
• 公共卫生实验室
• 私人或商业实验室
• 紧急护理诊所
• 医师实验室

COVID-19 诊断市场区域分析/见解

对 COVID-19 诊断市场进行了分析，并按国家、测试类型、产品、技术、样本类型、设置和最终用户提供了市场规模洞察和趋势，如上所述。

COVID-19 诊断市场报告涵盖的国家包括北美的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于北美拥有完善的医疗保健体系和众多现有的制药公司，北美在 COVID-19 诊断市场占据主导地位。

由于冠状病毒病例的增加以及众多行业参与者的存在，预计亚太地区将在 2022 年至 2029 年的预测期内实现最高增长率。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

COVID-19 诊断市场还为您提供了每个国家/地区资本设备医疗保健支出增长、COVID-19 诊断市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对 COVID-19 诊断市场的影响的详细市场分析。数据适用于 2010-2020 年的历史时期。

竞争格局和 COVID-19 诊断市场份额分析

COVID-19 诊断市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对 COVID-19 诊断市场的关注有关。

COVID-19 诊断市场的一些主要参与者包括：

• QIAGEN（德国）
• F.Hoffmann-La Roche Ltd（瑞士）
• Seegene Inc (韩国)
• SolGent 有限公司 (韩国)
• Curetis（德国）
• KURBO INDUSTRIES LTD.（日本）
• Devex（美国）
• 赛默飞世尔科技公司（美国）
• Mylab Discovery Solutions Pvt. Ltd (印度)
• 雅培（美国）
• 盖特生物科技股份有限公司 (中国)
• Biomaxima SA（波兰）
• CTK Biotech, Inc（美国）
• 疾病预防控制中心（美国）
• 华大基因（中国）
• Luminex 公司（美国）
• Avellino.com（美国）
• PerkinElmer Inc（美国）
• 丹纳赫（美国）
• 赛默飞世尔科技公司（美国）

SKU-55939